ctrl K

AI Score

Unlock

NLS Pharmaceutics AG (NLSP)

AI Score

Unlock

1.78

-0.06 (-3.26%)

At close: Mar 03, 2025, 3:59 PM

1.77

-0.56%

After-hours: Mar 03, 2025, 05:14 PM EST

NLS Pharmaceutics AG Income Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	11.41K	11.41K	10.05K	n/a	n/a	n/a	n/a
Gross Profit	-11.41K	-11.41K	-10.05K	n/a	n/a	n/a	n/a
Operating Income	-11.81M	-15.48M	-11.86M	-2.3M	-4.2M	-3.45K	-5.77M
Interest Income	n/a	100.87	68.13	233.70	819.71	n/a	890.40
Pretax Income	-12.17M	-16.5M	-11.95M	-2.86M	-5.45M	-5.15K	-6.66M
Net Income	-12.17M	-16.5M	-11.95M	-2.86M	-5.45M	-5.15K	-6.66M
Selling & General & Admin	5.9M	6.49M	5.93M	2.2M	2.49M	2.74K	1.44M
Research & Development	5.91M	8.98M	5.92M	99.58K	1.7M	708.45	4.32M
Other Expenses	0.00	10.04K	-17.32K	-328.37K	n/a	n/a	n/a
Operating Expenses	11.81M	15.47M	11.85M	2.3M	4.2M	3.45K	5.77M
Interest Expense	145.15K	100.87K	68.13K	233.7K	819.71K	n/a	890.4K
Selling & Marketing Expenses	n/a	6.49M	5.93M	2.2M	2.49M	n/a	n/a
Cost & Expenses	11.81M	15.48M	11.86M	2.3M	4.2M	3.45K	5.77M
Income Tax	n/a	2.00	-226.51K	-2.3K	-4.2K	n/a	-5.77K
Shares Outstanding (Basic)	38.18M	19.68M	14.75M	4.82M	11.14M	156.00	11.78M
Shares Outstanding (Diluted)	38.18M	19.68M	14.75M	4.82M	11.14M	156.00	11.78M
EPS (Basic)	-0.32	-0.84	-0.81	-0.59	-0.49	-32.99	-0.57
EPS (Diluted)	-0.32	-0.84	-0.81	-0.59	-0.49	-32.99	-0.57
EBITDA	-11.8M	-15.47M	-11.85M	n/a	-430.4K	n/a	-5.77M
Depreciation & Amortization	11.41K	11.41K	10.05K	2.3M	4.2M	3.45K	5.77M